Study Purpose:
Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.Study Status:
Recruiting
Disease:
Amyotrophic Lateral Sclerosis
Study Type:
Observational
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Ning Wang, MD,PhD, First Affiliated Hospital of Fujian Medical University
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
Qi-Jie Zhang, PhD / email hidden; JavaScript is required / 086-591-87982772
Full Study Summary:
Study Sponsor:
First Affiliated Hospital of Fujian Medical University
Estimated Enrollment:
2000
Estimated Study Start Date:
07 / 05 / 2019
Estimated Study Completion Date:
07 / 01 / 2059
Posting Last Modified Date:
03 / 22 / 2021
Date Study Added to neals.org:
07 / 05 / 2019
Minimum Age:
N/A
Maximum Age:
N/A
Inclusion Criteria:- Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible)
- Progressive muscular atrophy
- Primary lateral sclerosis
- Progressive bulbar palsy
Exclusion Criteria:
- History of serious head trauma or neuropsychiatric disease
- Decline to participate
Sub-Investigator : Wan-Jian Chen
Department of Neurology, First Affiliated Hospital of Fujian Medical University | Recruiting
Qi-Jie Zhang, PhD / 086-591-87982772 / email hidden; JavaScript is required
Ning Wang, PhD / 086-591-87982772 / email hidden; JavaScript is required
Principal Investigator : Ning Wang, MD,PhD
Fuzhou, Fujian
350005
China